Logo

American Heart Association

  21
  0


Final ID: MP1625

Population Screening for LV Dysfunction Using Single-Lead ECG-AI: Insights from the RURAL Study

Abstract Body (Do not enter title and authors here): Background. Moderate to severe left ventricular dysfunction (LVD), defined by a left ventricular ejection fraction (LVEF) <40%, is a key marker of heart failure with reduced ejection fraction (HFrEF). Early detection is crucial to reduce heart failure burden, yet no effective screening tool exists at the population level. While we and others have developed electrocardiographic artificial intelligence (ECG-AI) models to detect LVD, they are not yet appropriate for widespread screening due to selection bias—most ECGs used in training were collected for clinical, not screening, purposes. Community-based validation is needed to assess model generalizability.
Goal: This study aims to evaluate the performance of a previously developed ECG-AI model for left ventricular dysfunction (LVD) detection (Wake Forest’s ECG-AI model) among participants in the RURAL (Risk Underlying Rural Areas Longitudinal) Cohort Study.
Methods. Wake Forest’s ECG-AI Model is a ResNet-based deep learning algorithm originally developed to detect both LVD and HF with preserved ejection fraction. Trained on over 1 million lead I ECGs from Wake Forest School of Medicine, it achieved an AUC of 0.89 for identifying LVEF <40% on a held-out test set. External validation using ~100,000 ECGs from University of Tennessee Health Science Center, Memphis, TN, showed an AUC of 0.90. In the RURAL longitudinal cohort, participants had both 12-lead ECGs and echocardiograms at enrollment. Without calibration or fine-tuning, we applied the model to lead I ECGs from RURAL and calculated the AUC for detecting LVEF <40%.
Results. The analytical cohort included 1,276 RURAL participants from Alabama and Mississippi (65.5% women, 63.8% Black, mean age 48.5±11.0 years). Fifteen participants (1.2%) had LVEF<40%. The model achieved an AUC of 0.91 (95% CI: 0.80–1.00). At the optimal Youden Index threshold of 0.821, specificity was 95.4%, sensitivity 86.7%, negative predictive value 99.7%, and positive predictive value 18.3%. The model identified 71 participants as having LVEF<40%, including 13 true positives. Among the 58 false positives, 12 had mildly reduced LVEF between 40-50%.
Conclusion. The Wake Forest ECG-AI Model showed strong performance in identifying moderate to severe LVD using only a 10-second single-lead ECG in a community-based setting. Further validation in larger cohorts is needed to support its use as a scalable, non-invasive population screening tool.
  • Hayit, Tolga  ( WAKE FOREST SCHOOL OF MEDICINE , Winston Salem , North Carolina , United States )
  • Karabayir, Ibrahim  ( WAKE FOREST SCHOOL OF MEDICINE , Winston Salem , North Carolina , United States )
  • Ramachandran, Vasan  ( UT School of Public Health , San Antonio , Texas , United States )
  • Bloomfield, Gerald  ( DUKE UNIVERSITY MEDICAL CENTER , Durham , North Carolina , United States )
  • Douglas, Pamela  ( DUKE UNIVERSITY DUMC , Durham , North Carolina , United States )
  • Mcmanus, David  ( UMMS , Worcester , Massachusetts , United States )
  • Soliman, Elsayed  ( WAKE FOREST SCHOOL OF MEDICINE , Winston Salem , North Carolina , United States )
  • Herrington, David  ( WAKE FOREST SCHOOL OF MEDICINE , Winston Salem , North Carolina , United States )
  • Akbilgic, Oguz  ( WAKE FOREST SCHOOL OF MEDICINE , Winston Salem , North Carolina , United States )
  • Author Disclosures:
    tolga hayit: No Answer | Ibrahim Karabayir: DO NOT have relevant financial relationships | Vasan Ramachandran: DO NOT have relevant financial relationships | Gerald Bloomfield: DO NOT have relevant financial relationships | Pamela Douglas: DO have relevant financial relationships ; Researcher:HeartFlow:Past (completed) ; Other (please indicate in the box next to the company name):UpToDate- author:Active (exists now) ; Advisor:Novo Nordisk:Active (exists now) ; Advisor:Amgen:Active (exists now) ; Advisor:Foresite Labs:Past (completed) ; Advisor:Cleerly:Past (completed) | David McManus: No Answer | Elsayed Soliman: DO NOT have relevant financial relationships | David Herrington: No Answer | Oguz Akbilgic: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Drivers of Heart Failure: Environmental and Behavioral Factors

Sunday, 11/09/2025 , 09:15AM - 10:30AM

Moderated Digital Poster Session

More abstracts on this topic:

A blood test based on RNA-seq and machine learning for the detection of steatotic liver disease: A Pilot Study on Cardiometabolic Health

Poggio Rosana, Berdiñas Ignacio, La Greca Alejandro, Luzzani Carlos, Miriuka Santiago, Rodriguez-granillo Gaston, De Lillo Florencia, Rubilar Bibiana, Hijazi Razan, Solari Claudia, Rodríguez Varela María Soledad, Mobbs Alan, Manchini Estefania

Beta-blocker Treatment in Patients with Acute Myocardial Infarction and Mildly Reduced Ejection Fraction Undergoing Percutaneous Coronary Intervention

Jung Yu Jung, Kim Ung, Park Jong-seon, Park Jong-il, Jeong Young Sang, Jeong Jun-chang, Kim Sun Oh, Kim Hong-ju, Choi Kangun, Nam Jong-ho, Son Jang-won

More abstracts from these authors:
ECG-AI to Assist with the Classification of Low Ejection Fraction and Heart Failure with Preserved Ejection Fraction

Karabayir Ibrahim, Kitzman Dalane, Herrington David, Akbilgic Oguz, Davis Robert, Tootooni M. Samie, Chinthala Lokesh, Soliman Elsayed, Jefferies John, Baykaner Tina, Shah Sanjiv, Bertoni Alain

Short Term Heart Failure Readmission Risk Prediction from Single Lead ECG-AI Driven BNP Estimation

Karabayir Ibrahim, Gilbert Olivia, Sunkara Padageshwar, Herrington David, Akbilgic Oguz

You have to be authorized to contact abstract author. Please, Login
Not Available